<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">sibmed</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский научный медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Сибирский научный медицинский журнал</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2410-2512</issn><issn pub-type="epub">2410-2520</issn><publisher><publisher-name>ИЦиГ СО РАН</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18699/SSMJ20240402</article-id><article-id custom-type="elpub" pub-id-type="custom">sibmed-1608</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Оценка качества жизни пациентов с рассеянным склерозом c помощью шкалы SF-36</article-title><trans-title-group xml:lang="en"><trans-title>Assessment of the life quality of patients with multiple sclerosis using the SF-36 scale</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3138-8410</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стуров</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sturov</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Стуров Николай Владимирович, к.м.н.</p><p>117198, г. Москва, ул. Миклухо-Маклая, 6</p></bio><bio xml:lang="en"><p>Nicolaj V. Sturov, candidate of medical sciences</p><p>117198, Moscow, Miklukho-Maklaya st., 6</p></bio><email xlink:type="simple">pharm@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6673-5961</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тардов</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tardov</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тардов Михаил Владимирович, д.м.н.</p><p>117198, г. Москва, ул. Миклухо-Маклая, 6</p></bio><bio xml:lang="en"><p>Mikhail V. Tardov, doctor of medical sciences</p><p>117198, Moscow, Miklukho-Maklaya st., 6</p></bio><email xlink:type="simple">mvtardov@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2676-452X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Попова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Popova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Попова Екатерина Валерьевна, д.м.н.</p><p>127015, г. Москва, Писцовая ул., 10</p></bio><bio xml:lang="en"><p>Ekaterina V. Popova, doctor of medical sciences</p><p>127015, Moscow, Pistsovaya st., 10</p></bio><email xlink:type="simple">ani_retake1@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9319-2061</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Болдин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Boldin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Болдин Алексей Викторович, д.м.н.</p><p>119048, г. Москва, ул. Трубецкая, 8, стр. 2</p></bio><bio xml:lang="en"><p>Aleksej V. Boldin, doctor of medical sciences</p><p>119048, Moscow, Trubetskaya st., 8-2 </p></bio><email xlink:type="simple">drboldin@rambler.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1787-5722</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Страчук</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Strachuk</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Страчук Александр Георгиевич, к.м.н.</p><p>117198, г. Москва, ул. Миклухо-Маклая, 6 </p></bio><bio xml:lang="en"><p>Alexander G. Strachuk, candidate of medical sciences</p><p>117198, Moscow, Miklukho-Maklaya st., 6</p></bio><email xlink:type="simple">strachuk-ag@rudn.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0356-4667</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Талапбек к</surname><given-names>Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Talapbek k</surname><given-names>Sh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Талапбек кызы Ширин</p><p>117198, г. Москва, ул. Миклухо-Маклая, 6</p></bio><bio xml:lang="en"><p>Shirin Talapbek kyzy</p><p>117198, Moscow, Miklukho-Maklaya st., 6</p></bio><email xlink:type="simple">shirin250194@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский университет дружбы народов</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Peoples’ Friendship University of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Городская клиническая больница № 24</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow City Clinical Hospital No. 24</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Первый Московский государственный медицинский университет имени И.М. Сеченова Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>28</day><month>08</month><year>2024</year></pub-date><volume>44</volume><issue>4</issue><fpage>21</fpage><lpage>27</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Стуров Н.В., Тардов М.В., Попова Е.В., Болдин А.В., Страчук А.Г., Талапбек к Ш., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Стуров Н.В., Тардов М.В., Попова Е.В., Болдин А.В., Страчук А.Г., Талапбек к Ш.</copyright-holder><copyright-holder xml:lang="en">Sturov N.V., Tardov M.V., Popova E.V., Boldin A.V., Strachuk A.G., Talapbek k S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://sibmed.elpub.ru/jour/article/view/1608">https://sibmed.elpub.ru/jour/article/view/1608</self-uri><abstract><p>Распространенность рассеянного склероза (РС) неуклонно увеличивается не только в связи с ростом заболеваемости, но и по причине совершенствования диагностики и методов лечения. Соответственно, растет интерес к улучшению качества жизни (КЖ) хронических больных, для оценки которого применяются общие шкалы, а также шкалы, разработанные специально для РС. В настоящей работе осуществлен анализ публикаций, посвященных оценке КЖ больных РС с использованием неспецифической шкалы SF-36 за период с 2018 по 2023 г. Проведена оценка данных по всем восьми шкалам: физическое функционирование, ролевая деятельность, телесная боль, общее здоровье, жизнеспособность, социальное функционирование, эмоциональное состояние и психическое здоровье. Показана польза опросника SF-36 при ведении пациентов с РС врачом общей практики для комплексной оценки динамики КЖ на фоне лечения и при планировании дальнейших мер лечения и реабилитации. Однако неоднозначность результатов многочисленных исследований КЖ при РС, полученных с помощью опросника SF-36, требует продолжения исследований и совершенствования самого инструмента.</p></abstract><trans-abstract xml:lang="en"><p>The prevalence of multiple sclerosis (MS) is steadily increasing not only due to rising incidence, but also due to improvements in diagnosis and treatment. Accordingly, there is growing interest in improving the quality of life (QL) of chronic patients, for the assessment of which general scales are used, as well as scales developed specifically for MS. In this work, we analyzed publications devoted to assessing the quality of life of MS patients using the nonspecific SF-36 scale for the period from 2018 to 2023. Data were assessed on all eight scales: physical functioning, role functioning, bodily pain, general health, vitality, social functioning, emotional state and mental health. The usefulness of the SF-36 questionnaire has been shown in the management of patients with MS by a general practitioner for a comprehensive assessment of QL dynamics during treatment and in planning of further treatment and rehabilitation measures. However, the ambiguity of numerous QL studies results in MS obtained using the SF-36 questionnaire requires continued research and improvement of the instrument itself.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рассеянный склероз</kwd><kwd>качество жизни</kwd><kwd>физическое функционирование</kwd><kwd>ролевое функционирование</kwd><kwd>интенсивность боли</kwd><kwd>общее состояние здоровья</kwd><kwd>жизненная активность</kwd><kwd>социальное функционирование</kwd><kwd>психическое здоровье</kwd><kwd>эмоциональное состояние</kwd></kwd-group><kwd-group xml:lang="en"><kwd>multiple sclerosis</kwd><kwd>quality of life</kwd><kwd>physical functioning</kwd><kwd>role functioning</kwd><kwd>pain intensity</kwd><kwd>general health</kwd><kwd>vitality</kwd><kwd>social functioning</kwd><kwd>mental health</kwd><kwd>emotional state</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации «Рассеянный склероз». 2022. Режим доступа: https://cr.minzdrav.gov.ru/schema/739_1.</mixed-citation><mixed-citation xml:lang="en">Clinical guidelines «Multiple Sclerosis». 2022. Available at: https://cr.minzdrav.gov.ru/schema/739_1 [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Niino M., Fukumoto S., Okuno T., Sanjo N., Fukaura H., Mori M., Ohashi T., Takeuchi H., Shimizu Y., Fujimori J. … Mifune N. Health-related quality of life in Japanese patients with multiple sclerosis. J. Neurol. 2023;270(2):1011–1018. doi: 10.1007/s00415-022-11453-9</mixed-citation><mixed-citation xml:lang="en">Niino M., Fukumoto S., Okuno T., Sanjo N., Fukaura H., Mori M., Ohashi T., Takeuchi H., Shimizu Y., Fujimori J. … Mifune N. Health-related quality of life in Japanese patients with multiple sclerosis. J. Neurol. 2023;270(2):1011–1018. doi: 10.1007/s00415-022-11453-9</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Oliva Ramirez A., Keenan A., Kalau O., Worthington E., Cohen L., Singh, S. Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review. BMC Neurol. 2021;21(1):468. doi: 10.1186/s12883-021-02396-1</mixed-citation><mixed-citation xml:lang="en">Oliva Ramirez A., Keenan A., Kalau O., Worthington E., Cohen L., Singh, S. Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review. BMC Neurol. 2021;21(1):468. doi: 10.1186/s12883-021-02396-1</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gil-González I., Martín-Rodríguez A., Conrad R., Pérez-San-Gregorio M.Á. Quality of life in adults with multiple sclerosis: a systematic review. BMJ Open. 2020;10(11):e041249. doi: 10.1136/bmjopen-2020-041249</mixed-citation><mixed-citation xml:lang="en">Gil-González I., Martín-Rodríguez A., Conrad R., Pérez-San-Gregorio M.Á. Quality of life in adults with multiple sclerosis: a systematic review. BMJ Open. 2020;10(11):e041249. doi: 10.1136/bmjopen-2020-041249</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt S., Jöstingmeyer P. Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study. Mult. Scler. Relat. Disord. 2019;(35):262–269. doi: 10.1016/j.msard.2019.07.029</mixed-citation><mixed-citation xml:lang="en">Schmidt S., Jöstingmeyer P. Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study. Mult. Scler. Relat. Disord. 2019;(35):262–269. doi: 10.1016/j.msard.2019.07.029</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ochoa-Morales A., Hernández-Mojica T., Paz-Rodríguez F., Jara-Prado A., Trujillo-De Los Santos Z., Sánchez-Guzmán M. A., Guerrero-Camacho J.L., Corona-Vázquez T., Flores J., Camacho-Molina A., Rivas-Alonso V., Dávila-Ortiz de Montellano D.J. Quality of life in patients with multiple sclerosis and its association with depressive symptoms and physical disability. Mult. Scler. Relat. Disord. 2019;(36):101386. doi: 10.1016/j.msard.2019.101386</mixed-citation><mixed-citation xml:lang="en">Ochoa-Morales A., Hernández-Mojica T., Paz-Rodríguez F., Jara-Prado A., Trujillo-De Los Santos Z., Sánchez-Guzmán M. A., Guerrero-Camacho J.L., Corona-Vázquez T., Flores J., Camacho-Molina A., Rivas-Alonso V., Dávila-Ortiz de Montellano D.J. Quality of life in patients with multiple sclerosis and its association with depressive symptoms and physical disability. Mult. Scler. Relat. Disord. 2019;(36):101386. doi: 10.1016/j.msard.2019.101386</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">The Multiple Sclerosis International Federation. Atlas of MS, 3rd Ed. Available at: https://www. msif.org/wp-content/uploads/2020/12/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf</mixed-citation><mixed-citation xml:lang="en">The Multiple Sclerosis International Federation. Atlas of MS, 3rd Ed. Available at: https://www. msif.org/wp-content/uploads/2020/12/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health Organization. Soc. Sci. Med. 1995;41(10):1403–1409. doi: 10.1016/0277-9536(95)00112-K</mixed-citation><mixed-citation xml:lang="en">The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health Organization. Soc. Sci. Med. 1995;41(10):1403–1409. doi: 10.1016/0277-9536(95)00112-K</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Wiebe S., Guyatt G., Weaver B., Matijevic S., Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J. Clin. Epidemiol. 2003;56(1):52–60. doi: 10.1016/s0895-4356(02)00537-1</mixed-citation><mixed-citation xml:lang="en">Wiebe S., Guyatt G., Weaver B., Matijevic S., Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J. Clin. Epidemiol. 2003;56(1):52–60. doi: 10.1016/s0895-4356(02)00537-1</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kuspinar A., Mayo N.E. Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis? Health Qual. Life Outcomes. 2013;(11):71. doi: 10.1186/1477-7525-11-71</mixed-citation><mixed-citation xml:lang="en">Kuspinar A., Mayo N.E. Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis? Health Qual. Life Outcomes. 2013;(11):71. doi: 10.1186/1477-7525-11-71</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kurtzke J.F. On the origin of EDSS. Mult. Scler. Relat. Disord. 2015;4(2):95–103. doi: 10.1016/j.msard.2015.02.003</mixed-citation><mixed-citation xml:lang="en">Kurtzke J.F. On the origin of EDSS. Mult. Scler. Relat. Disord. 2015;4(2):95–103. doi: 10.1016/j.msard.2015.02.003</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Vickrey B.G., Hays R.D., Harooni R., Myers L.W., Ellison G.W. A health-related quality of life measure for multiple sclerosis. Qual. Life Res. 1995;4(3):187–206. doi: 10.1007/BF02260859</mixed-citation><mixed-citation xml:lang="en">Vickrey B.G., Hays R.D., Harooni R., Myers L.W., Ellison G.W. A health-related quality of life measure for multiple sclerosis. Qual. Life Res. 1995;4(3):187–206. doi: 10.1007/BF02260859</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Simeoni M., Auquier P., Fernandez O., Flachenecker P., Stecchi S., Constantinescu C., Idiman E., Boyko A., Beiske A., Vollmer T., Beresniak A. MusiQol study group. Validation of the Multiple Sclerosis International Quality of Life questionnaire. Mult. Scler. 2008;14(2):219–230. doi: 10.1177/1352458507080733</mixed-citation><mixed-citation xml:lang="en">Simeoni M., Auquier P., Fernandez O., Flachenecker P., Stecchi S., Constantinescu C., Idiman E., Boyko A., Beiske A., Vollmer T., Beresniak A. MusiQol study group. Validation of the Multiple Sclerosis International Quality of Life questionnaire. Mult. Scler. 2008;14(2):219–230. doi: 10.1177/1352458507080733</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ware J.E. Jr., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care. 1992;30(6):473–483.</mixed-citation><mixed-citation xml:lang="en">Ware J.E. Jr., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care. 1992;30(6):473–483.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Новик А.А, Ионова Т.И. Руководство по исследованию качества жизни в медицине. М., ОЛМА-ПРЕСС, 2002. 314 с.</mixed-citation><mixed-citation xml:lang="en">Novik A.A., Ionova T.I. Guidelines for quality of life research in medicine. M., OLMA-PRESS, 2002. 314 p. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Pashazadeh Kan F., Hoseinipalangi Z., Ahmadi N., Hosseinifard H., Dehnad A., Sadat Hoseini B., Tohidi Asl M., Ghashghaee A. Global, regional and national quality of life in patients with multiple sclerosis: a global systematic review and meta-analysis. BMJ Support. Palliat. Care. 2022;12(2):158–166. doi: 10.1136/bmjspcare-2020-002604</mixed-citation><mixed-citation xml:lang="en">Pashazadeh Kan F., Hoseinipalangi Z., Ahmadi N., Hosseinifard H., Dehnad A., Sadat Hoseini B., Tohidi Asl M., Ghashghaee A. Global, regional and national quality of life in patients with multiple sclerosis: a global systematic review and meta-analysis. BMJ Support. Palliat. Care. 2022;12(2):158–166. doi: 10.1136/bmjspcare-2020-002604</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Никонова Е.В., Абдуллаев М.Б., Первунина А.В., Аброськина М.В. Опыт работы кабинета демиелинизирующей патологии города Красноярска по исследованию качества жизни пациентов с рассеянным склерозом. Сиб. мед. обозрение. 2021; (3):73–79. doi: 10.20333/25000136-2021-3-73-79</mixed-citation><mixed-citation xml:lang="en">Nikonova E.V., Abdullaev M.B., Pervunina A.V., Abroskina M.V. Work experience of the demyelination pathology unit in the city of krasnoyarsk related to investigation of the quality of life of patients with multiple sclerosis. Sibirskoe meditsinskoe obozrenie = Siberian Medical Review. 2021;(3):73–79. [In Russian]. doi: 10.20333/25000136-2021-3-73-79</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Бойко А.Н., Бахтиярова К.З., Шерман М.А., Гончарова З.А., Смагина И.В., Хайбуллин Т.И., Бабичева Н.Н., Спирина Н.Н., ЯмпольскаяГостева И.А., Соколова И.А. ... Лозовская И.С. Результаты исследования качества жизни у больных с высокоактивным рассеянным склерозом в России. Неврол., нейропсихиатрия, психосоматика. 2022; 14(1S):9–15. doi: 10.14412/2074-2711-2022-1S-9-15</mixed-citation><mixed-citation xml:lang="en">Bojko A.N., Bakhtiyarova K.Z., Sherman M.A., Goncharova Z.A., Smagina I.V., Hajbullin T.I., Babicheva N.N., Spirina N.N., Yampol’skaya-Gosteva I.A., Sokolova I.A. ... Lozovskaya I.S. Results of the study of quality of life in patients with highly active multiple sclerosis in Russia. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2022;14(1S):9–15. [In Russian]. doi: 10.14412/2074-2711-2022-1S-9-15</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hyncicova E., Kalina A., Vyhnalek M., Nikolai T., Martinkovic L., Lisy J., Hort J., Meluzinova E., Laczó J. Health-related quality of life, neuropsychiatric symptoms and structural brain changes in clinically isolated syndrome. PloS One. 2018;13(7):e0200254. doi: 10.1371/journal.pone.0200254</mixed-citation><mixed-citation xml:lang="en">Hyncicova E., Kalina A., Vyhnalek M., Nikolai T., Martinkovic L., Lisy J., Hort J., Meluzinova E., Laczó J. Health-related quality of life, neuropsychiatric symptoms and structural brain changes in clinically isolated syndrome. PloS One. 2018;13(7):e0200254. doi: 10.1371/journal.pone.0200254</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Faraclas E., Lynn J., Lau J. D., Merlo A. Health-related quality of life in people with multiple sclerosis: How does this population compare to population-based norms in different health domains? J. Patient Rep. Outcomes. 2022;6(1):12. doi: 10.1186/s41687-022-00415-4</mixed-citation><mixed-citation xml:lang="en">Faraclas E., Lynn J., Lau J. D., Merlo A. Health-related quality of life in people with multiple sclerosis: How does this population compare to population-based norms in different health domains? J. Patient Rep. Outcomes. 2022;6(1):12. doi: 10.1186/s41687-022-00415-4</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Зарубина Н.В., Спирин Н.Н. Влияние депрессии на качество жизни больных рассеянным склерозом. Неврол., нейропсихиатрия, психосоматика. 2023;15(3):41–47. doi: 10.14412/2074-2711-2023-3-41-47</mixed-citation><mixed-citation xml:lang="en">Zarubina N.V., Spirin N.N. Impact of depression on the quality of life of patients with multiple sclerosis. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(3):41–47. [In Russian]. doi: 10.14412/2074-2711-2023-3-41-47</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Alhazzani A.A., Alqahtani M.S., Alahmari M.S., Asiri M.A., Alamri N.M., Sarhan L.A., Alkhashrami S.S., Asiri A.A. Quality of life assessment among multiple sclerosis patients in Saudi Arabia. Neurosciences (Riyadh). 2018;23(2):140–147. doi: 10.17712/nsj.2018.2.20170335</mixed-citation><mixed-citation xml:lang="en">Alhazzani A.A., Alqahtani M.S., Alahmari M.S., Asiri M.A., Alamri N.M., Sarhan L.A., Alkhashrami S.S., Asiri A.A. Quality of life assessment among multiple sclerosis patients in Saudi Arabia. Neurosciences (Riyadh). 2018;23(2):140–147. doi: 10.17712/nsj.2018.2.20170335</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Лорина Л.В., Джапаралиева Н.Т., Буршинов А.О. Показатели качества жизни при различных типах течения рассеянного склероза. Медицина. 2017;5(2):88–96.</mixed-citation><mixed-citation xml:lang="en">Lorina L.V., Dzhaparalieva N.T., Burshinov A.O. Quality of life indicators in different types of multiple sclerosis. Meditsina = Medicine. 2017;5(2):88–96. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Топузова М.П., Алексеева Т.М., Панина Е.Б., Москалюк Г.С. Оценка качества жизни у пациентов с рассеянным склерозом: cб. тез. докл. XXI Давиденковских чтений, Санкт-Петербург, 26–27 сентября 2019 г. СПб., 2019. С. 330–331.</mixed-citation><mixed-citation xml:lang="en">Topuzova M.P., Alekseeva T.M., Panina E.B., Moskalyuk G.S. Assessment of quality of life in patients with multiple sclerosis: сoll. thes. rep. XXI Davidenkov Readings, Saint-Petersburg, September 26–27, 2019. Saint-Petersburg, 2019. P. 330–331. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Rezapour A., Almasian Kia A., Goodarzi S., Hasoumi M., Nouraei Motlagh S., Vahedi S. The impact of disease characteristics on multiple sclerosis patients’ quality of life. Epidemiol. Health. 2017;(39):e2017008. doi: 10.4178/epih.e2017008</mixed-citation><mixed-citation xml:lang="en">Rezapour A., Almasian Kia A., Goodarzi S., Hasoumi M., Nouraei Motlagh S., Vahedi S. The impact of disease characteristics on multiple sclerosis patients’ quality of life. Epidemiol. Health. 2017;(39):e2017008. doi: 10.4178/epih.e2017008</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Magyari M., Sorensen P.S. Comorbidity in multiple sclerosis. Front. Neurol. 2020;(11):851. doi: 10.3389/fneur.2020.00851</mixed-citation><mixed-citation xml:lang="en">Magyari M., Sorensen P.S. Comorbidity in multiple sclerosis. Front. Neurol. 2020;(11):851. doi: 10.3389/fneur.2020.00851</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Lo L.M.P., Taylor B.V., Winzenberg T., Palmer A.J., Blizzard L., Ahmad H., Hussain M.A., van der Mei I. Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis. J. Neurol. 2021;268(2):569– 581. doi: 10.1007/s00415-020-10195-w</mixed-citation><mixed-citation xml:lang="en">Lo L.M.P., Taylor B.V., Winzenberg T., Palmer A.J., Blizzard L., Ahmad H., Hussain M.A., van der Mei I. Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis. J. Neurol. 2021;268(2):569– 581. doi: 10.1007/s00415-020-10195-w</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Strober L.B. Quality of life and psychological well-being in the early stages of multiple sclerosis (MS): Importance of adopting a biopsychosocial model. Disabil. Health J. 2018;11(4):555–561. doi: 10.1016/j.dhjo.2018.05.003</mixed-citation><mixed-citation xml:lang="en">Strober L.B. Quality of life and psychological well-being in the early stages of multiple sclerosis (MS): Importance of adopting a biopsychosocial model. Disabil. Health J. 2018;11(4):555–561. doi: 10.1016/j.dhjo.2018.05.003</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt S., Jöstingmeyer P. Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study. Mult. Scler. Relat. Disord. 2019;(35):262–269. doi: 10.1016/j.msard.2019.07.029</mixed-citation><mixed-citation xml:lang="en">Schmidt S., Jöstingmeyer P. Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study. Mult. Scler. Relat. Disord. 2019;(35):262–269. doi: 10.1016/j.msard.2019.07.029</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Russell R.D., Black L.J., Pham N.M., Begley A. The effectiveness of emotional wellness programs on mental health outcomes for adults with multiple sclerosis: a systematic review and meta-analysis. Mult. Scler. Relat. Disord. 2020;(44):102171. doi: 10.1016/j.msard.2020.102171</mixed-citation><mixed-citation xml:lang="en">Russell R.D., Black L.J., Pham N.M., Begley A. The effectiveness of emotional wellness programs on mental health outcomes for adults with multiple sclerosis: a systematic review and meta-analysis. Mult. Scler. Relat. Disord. 2020;(44):102171. doi: 10.1016/j.msard.2020.102171</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Simpson R., Posa S., Langer L., Bruno T., Simpson S., Lawrence M., Booth J., Mercer S.W., Feinstein A., Bayley M. A systematic review and meta-analysis exploring the efficacy of mindfulness-based interventions on quality of life in people with multiple sclerosis. Journal of Neurology. 2023;270(2):726–745. doi: 10.1007/s00415-022-11451-x</mixed-citation><mixed-citation xml:lang="en">Simpson R., Posa S., Langer L., Bruno T., Simpson S., Lawrence M., Booth J., Mercer S.W., Feinstein A., Bayley M. A systematic review and meta-analysis exploring the efficacy of mindfulness-based interventions on quality of life in people with multiple sclerosis. Journal of Neurology. 2023;270(2):726–745. doi: 10.1007/s00415-022-11451-x</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Dunne J., Chih H. J., Begley A., Daly A., Gerlach R., Schütze R., Castell E., Byrne J., Black. J. A randomised controlled trial to test the feasibility of online mindfulness programs for people with multiple sclerosis. Mult. Scler. Relat. Disord. 2021;(48):102728. doi: 10.1016/j.msard.2020.102728</mixed-citation><mixed-citation xml:lang="en">Dunne J., Chih H. J., Begley A., Daly A., Gerlach R., Schütze R., Castell E., Byrne J., Black. J. A randomised controlled trial to test the feasibility of online mindfulness programs for people with multiple sclerosis. Mult. Scler. Relat. Disord. 2021;(48):102728. doi: 10.1016/j.msard.2020.102728</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
